TENAYA THERAPEUTICS INC (TNYA) Stock Analyst Earnings Estimates
NASDAQ:TNYA - Nasdaq - US87990A1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 561.53% | N/A 1,125.87% | N/A 180.13% | N/A 113.60% | N/A 87.33% | N/A 16.91% | N/A 62.06% | ||||||
| EBITDA YoY % growth | -25.72M | -36.43M -41.64% | -69.85M -91.74% | -119.15M -70.58% | -122.506M -2.82% | N/A 9.45% | N/A -8.61% | N/A -22.55% | N/A 16.68% | N/A 39.14% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.71M | -38.91M -40.42% | -72.81M -87.12% | -125.62M -72.53% | -131.193M -4.44% | N/A 9.25% | N/A -4.82% | N/A -10.44% | N/A 135.78% | N/A 786.59% | N/A 175.38% | N/A 106.56% | N/A 17.45% | N/A 72.61% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.79 70.82% | -1.67 40.14% | N/A 17.47% | N/A 7.86% | N/A -2.41% | N/A 146.80% | N/A 497.17% | N/A 158.61% | N/A 93.81% | N/A 14.84% | N/A 15.07% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 20.67% | -0.33 17.76% | -0.33 1.75% | -0.33 -9.65% | -0.33 -2.86% | -0.38 -14.73% | -0.38 -14.50% | -0.40 -22.48% | -0.41 -26.56% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | -29.274M -28.63% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.725M 8.65% | -32.63M 3.35% | -34.336M -11.40% | -37.243M -39.43% | -40.968M -42.62% | -41.766M -28.00% | -42.591M -24.04% | -45.358M -21.79% | -50.897M -24.24% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 23.08% | -0.37 | 0.07 | 19.97% |
| Q2 2024 Q2Q % growth | -0.34 24.44% | -0.40 | 0.06 | 14.77% |
| Q1 2024 Q2Q % growth | -0.40 6.98% | -0.43 | 0.03 | 7.26% |
| Q4 2023 Q2Q % growth | -0.40 34.43% | -0.45 | 0.05 | 10.62% |
| Q3 2023 Q2Q % growth | -0.39 47.30% | -0.48 | 0.09 | 19.14% |
| Q2 2023 Q2Q % growth | -0.45 34.78% | -0.51 | 0.06 | 12.35% |
| Q1 2023 Q2Q % growth | -0.43 42.67% | -0.57 | 0.14 | 25.16% |
| Q4 2022 Q2Q % growth | -0.61 3.17% | -0.66 | 0.05 | 7.99% |
| Q3 2022 Q2Q % growth | -0.74 -8.82% | -0.65 | -0.09 | -13.06% |
| Q2 2022 Q2Q % growth | -0.69 94.80% | -0.77 | 0.08 | 10.76% |
| Q1 2022 Q2Q % growth | -0.75 | -0.66 | -0.09 | -14.00% |
| Q4 2021 Q2Q % growth | -0.63 | -0.62 | -0.01 | -2.09% |
| Q3 2021 Q2Q % growth | -0.68 | -0.72 | 0.04 | 5.44% |
| Q2 2021 Q2Q % growth | -13.26 | -7.32 | -5.94 | -81.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 11.95% | 0% | 3.1% |
| Revenue | N/A | -100% | N/A | -100% |